Skip to main content
. 2018 Aug 7;8:11811. doi: 10.1038/s41598-018-30211-4

Table 2.

Descriptive data of 8558 individuals with decompression surgery 2008–2010 and two matched comparison groups: (a) individuals with dorsopathies, but no surgery 2008–2010 and (b) the general population without dorsopathies or surgery 2001–2013.

Surgery (N = 8558) Comparison group 1: Dorsopathy, no surgery (N = 8558) Comparison group 2: General population (N = 8558)
Sociodemographic factors
Type of living area
Big cities 3314 (38.7) 3405 (39.8) 3122 (36.5)
Medium sized cities 2918 (34.1) 2852 (33.3) 2966 (34.7)
Small town 2326 (27.2) 2301 (26.9) 2470 (28.9)
Family situation
Married or cohabiting/with no children at home 1461 (17.1) 1372 (16.0) 1351 (15.8)
Married or cohabiting/with children at home 3744 (43.7) 3626 (42.4) 3642 (42.6)
Single with no children at home 2514 (29.4) 2740 (32.0) 2858 (33.4)
Single with children at home 839 (9.8) 820 (9.6) 707 (8.3)
Unemployment in the year before inclusion
No unemployment 7810 (91.3) 7692 (89.9) 7793 (91.1)
1–179 days 555 (6.5) 635 (7.4) 555 (6.5)
≥180 days 193 (2.3) 231 (2.7) 210 (2.5)
Clinical factors
Work disability a 3 years before inclusion 6046 (70.7) 4709 (55.0) 2333 (27.3)
Work disability 3 years after inclusion 7605 (88.9) 5041 (58.9) 2282 (26.7)
Previous and current dorsopathies
Dorsopathiesb 3 years before inclusion 7454 (87.1) 989 (11.6)
Fusion surgery at inclusion 1580 (18.5)
Other Somatic diagnoses c 3 years before and at inclusion 5720 (66.8) 5959 (69.6) 4215 (49.3)
Analgesics d 1 years before inclusion
No Analgesics 1644 (19.2) 4501 (52.6) 7615 (89.0)
Low dose (0–0.5 DDDe) 4910 (57.4) 3130 (36.6) 806 (9.4)
Medium dose (0.5–1.5 DDD) 1575 (18.4) 635 (7.4) 101 (1.2)
High dose (>1.5 DDD) 429 (5.0) 292 (3.4) 36 (0.4)
Previous mental disorders
Common mental disorders f 3 years before and at inclusion 526 (6.2) 677 (7.9) 291 (3.4)
Other mental diagnoses g 3 years before and at inclusion 446 (5.2) 581 (6.8) 331 (3.9)
Anxiolytics h 1 year before inclusion
No Anxiolytics 7341 (85.8) 7546 (88.2) 8161 (95.4)
Low dose (0–0.5 DDD) 1048 (12.3) 820 (9.6) 323 (3.8)
Medium dose (0.5–1.5 DDD) 113 (1.3) 116 (1.4) 50 (0.6)
High dose (>1.5 DDD) 56 (0.7) 76 (0.9) 24 (0.3)
Hypnotics/Sedatives i 1 year before inclusion
No Hypnotics/Sedatives 7161 (83.7) 7277 (85.0) 7981 (93.3)
Low dose (0–0.5 DDD) 787 (9.2) 744 (8.7) 341 (4.0)
Medium dose (0.5–1.5 DDD) 396 (4.6) 360 (4.2) 162 (1.9)
High dose (>1.5 DDD) 214 (2.5) 177 (2.1) 74 (0.9)
Antidepressants j 1 year before inclusion
No Antidepressants 6846 (80.0) 7028 (82.1) 7801 (91.2)
Low dose (0–0.5 DDD) 727 (8.5) 606 (7.1) 251 (2.9)
Medium dose (0.5–1.5 DDD) 633 (7.4) 601 (7.0) 350 (4.1)
High dose (>1.5 DDD) 352 (4.1) 323 (3.8) 156.8)

aWork disability was defined as having had at least one day of reimbursed sickness absence or disability pension in this period.

bSpondylopathies, (International Classification of Diseases version 10 (ICD-10): M47.8, M47.9, M47.9 K, M48.0, M48.0 K, M48.8, M48.8 K and M48.8 W), Radiculopathies (ICD-10: M51.1, M51.1 K and M54.1) and other dorsopathies (ICD-10: M54.3, M54.4, M54.5, M53.8 and M53.9).

cAll diagnoses except mental diagnoses (F00-F99), dorsopathic diagnoses (M40-M54), uncomplicated delivery (ICD-10: O80), external causes of morbidity and mortality (ICD-10: V01-Y98), factors influencing health status and contact with health services (ICD-10: Z00-Z99), and codes for special purposes (ICD-10: U00-U89).

dAnatomical therapeutic chemical classification system (ATC) codes: N02A, N02B.

eDefined daily dose (DDD) is the assumed average maintenance dose per day for a drug used for its main indication in adults.

fICD-10: F32, F33 and F40- F43.

gICD-10: F00-F31, F34-F39 and F44-F99.

hATC Code N05B.

iATC Code N05C.

jATC code: N06.